A new study from UCLA finds a visit from human-controlled robot encourages a positive outlook and improves medical interactions for hospitalized children.
Health care personnel who received a two-dose regimen of Pfizer–BioNTech vaccine had an 89% lower risk for symptomatic illness than those who were unvaccinated. For those who received the two-dose regimen of the Moderna vaccine, the risk was reduced by 96%.
Cinco de los sistemas de salud sin fines de lucro más grandes del condado de Los Ángeles incluyendo hospitales, clínicas e instalaciones en toda la región, anunciaron la campaña más reciente para su coalición bettertogether.health.
A UCLA study reveals new insights into the wiring of a major brain circuit that is attacked by Parkinson’s and Huntington’s disease. The findings could hone scientists’ understanding of how diseases arise in the human brain and pinpoint new therapeutic targets.
Cesarean birth rates are on the rise, and this is especially true for high-risk pregnant women who have undergone organ transplantation. While cesarean births account for 31% of all deliveries in the United States, the rate of cesarean births for pregnant people with kidney transplants is 62.6% and 44.6% for liver transplants.
LA's five most prominent health systems remain united to save lives, pivoting resources to unveil a multi-media public service education campaign to convince those avoiding care during the pandemic to get back to their health
A UCLA study suggests that many physicians may not have the knowledge or training to properly recognize how Lyme disease appears on the skin of Black patients.
Join the Fielding School's UCLA Center for Health Policy Research (UCLA CHPR) as the center brings together public health leaders, community advocates, policymakers, and other thought leaders to help identify past successes and lessons learned, so that California can invest effectively with evidence-based solutions to creating a healthier, more prosperous California for all.
Dr. Lara Cushing, whose research identifies the disproportionate impacts of harmful environmental exposures on low-income populations and communities of color, has been appointed the Jonathan and Karin Fielding Presidential Chair in Health Equity at the UCLA Fielding School of Public Health, where Cushing is an assistant professor in the Department of Environmental Health Sciences.
Dr. Alice Soragni of the UCLA Jonsson Comprehensive Cancer Center has received a $2.5 million grant from the National Cancer Institute to develop lab-grown mini tumors that can help identify treatments for rare types of neuroendocrine cancer.
An inexpensive anti-seizure medication markedly improves learning and memory and other cognitive functions in Alzheimer’s patients who have epileptic activity in their brains, according to a study published in the Sept. 27th issue of JAMA Neurology.
UCLA-led research finds ozone exposure contributes to the development of Type 2 diabetes; team examining Californians’ health finds pattern holds true, particularly among those with higher levels of leisure-time outdoor physical activity
Release of the 2021 State Latino GDP Report: California
A new $13.3 million contract from the National Institutes of Health’s Rapid Acceleration of Diagnostics initiative, or RADx, will enable the UCLA SwabSeq lab to expand its capacity to process thousands of COVID-19 tests a day.
Patients with dementia who had signs and risk factors of a pulmonary embolism, or a blood clot in the lungs, were much less likely to be tested for pulmonary embolism than patients without dementia who had the same signs and risk factors.
Early results from a UCLA-led clinical trial found treating women with estrogen receptor (ER)-positive and human epidermal growth factor receptor-2 (HER2)-negative early breast cancers with a novel type of anti-hormonal therapy, called an oral selective estrogen receptor degrader (SERD), led to clinically meaningful reductions in tumor activity prior to surgery.
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that treating women with HER2 positive metastatic breast cancer with the HER2-targeting antibody-drug conjugate trastuzumab deruxtecan (T-DXd) significantly prolongs the length of time the disease is controlled and cancer growth is halted when compared to the current standard of care, trastuzumab emtansine (T-DM1).
A paper detailing the method that led to the US Food and Drug Administration approval for PSMA PET imaging, which was led by UCLA and UCSF and their nuclear medicine teams, was recently published in JAMA Oncology.
Physicians prescribed opioids more often to their white patients who complained of new-onset low back pain than to their Black, Asian and Hispanic patients during the early days of the national opioid crisis, when prescriptions for these powerful painkillers were surging but their dangers were not fully apparent.
Some medical procedures can put health care workers at higher risk for contracting COVID-19 and other respiratory diseases. With these high-risk procedures, it’s important that health care providers have access to personal protective equipment (PPE), including N95 masks. However, not all procedures that may seem high risk have that designation.
In this session, panelists Dr. Robert Kim-Farley (professor, departments of Epidemiology & Community Health Sciences) and Dr. Anne Rimoin (professor, Department of Epidemiology & director, Center for Global and Immigrant Health) will discuss the latest news on the pandemic in a conversation moderated by Dr. Ron Brookmeyer, dean of the UCLA Fielding School of Public Health & distinguished professor, Department of Biostatistics.
A new study from scientists at the UCLA Jonsson Comprehensive Cancer Center found that emerging drugs that activate the protein STING, a well-established regulator of immune cell activation, substantially alter the activity of metabolic pathways responsible for generating the nucleotide building blocks for DNA.
Researchers at UCLA Health have been awarded $3 million from the Governor’s Office of Planning and Research (OPR) to develop a statewide stress surveillance system and establish a network of physicians/scientists to study how stress impacts the body and what can be done to increase resiliency.
People who are prescribed the anti-coagulant apixaban cite six major reasons for failing to adhere to their prescriptions, including cost and potential bleeding.
Physicians and scientists from UCLA will be joining thousands of urology experts on Sept. 10 to Sept. 13 for the virtual American Urological Association (AUA) Annual Meeting.
The troubling news and images emerging from Afghanistan as American troops withdraw from the region after 20 years is causing a spike in post-traumatic stress among veterans at home, says UCLA Health psychiatrist Bruce Kagan, MD, PhD.
Scientists Dr. Cristina Puig-Saus and Dr. Daniel Shin from the UCLA Jonsson Comprehensive Cancer Center have received a $1 million Translational Research Award from the U.S. Department of Defense Melanoma Research Program to help advance the use of chimeric antigen receptor, or CAR, T cell therapy as a treatment for people with acral, mucosal and uveal melanomas.
A new preclinical study led by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that treating people who have aggressive cancers, including melanoma, pancreatic and colorectal cancers, with immune checkpoint inhibitors, quickly followed with mutation-targeted therapy, can help overcome treatment resistance and help people live longer.
Research team led by Dr. Timothy Brewer, UCLA Fielding School of Public Health professor of epidemiology, finds almost 900 million Africans live without on-site water, while 700 million people lack in-home soap/washing facilities
UCLA researchers have successfully grown restorative brain cells in large batches suitable for transplantation in patients. The therapy is designed to repair damage to the brain from white matter stroke, a “silent stroke” that can kick off years of cognitive deterioration and can accelerate Alzheimer’s disease. A new paper is published in the journal Stem Cell Research.
Trusting health advice from governments and health workers, and feeling positively about vaccines, are strongly associated with trust in institutions, according to a peer-reviewed study from UCLA researchers published in the August edition of the journal Health Affairs.
The risk that both tobacco and electronic cigarettes can pose to regular smokers’ health has been well documented, but a new UCLA study illustrates just how quickly vaping can affect the cells of even healthy younger nonsmokers.
Emergency department physicians who saw patients with a pulmonary embolism—a blood clot in the lung—were about 15% likelier over the next 10 days to test subsequent patients for the same thing.
Women with frequent urinary tract infections say they’re unhappy with what they perceive as their doctors’ overuse of antibiotics and with the limited treatment options available to them, according to a study led by researchers from UCLA and Cedars-Sinai.
A research team from the UCLA Youth Stress and Mood Program at UCLA's Jane and Terry Semel Institute for Neuroscience and Human Behavior has been approved to lead a $13 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to compare two evidence-based interventions for reducing suicide attempts and improving patient outcomes for youth presenting to emergency departments.
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.
Job strain and family strain are found to be linked to major depressive episodes and may have different effects on men and women, according to a study from UCLA researchers published in the August edition of the Journal of Psychosomatic Research.
Researchers from UCLA and Cedars-Sinai have developed a new way to detect a potentially life-threatening condition that can occur during pregnancy. The condition, placenta accreta spectrum disorder, occurs when the placenta grows too deeply into the uterine wall and fails to detach from the uterus after childbirth. It can lead to significant blood loss during pregnancy and delivery, requiring blood transfusions and intensive care, and it can result in serious illness and infection and can even be fatal for the mother. The condition occurs in less than 0.5% of pregnancies.
Removing a protein that is often overexpressed in a rare and aggressive subtype of leukemia can help to slow the cancer’s development and significantly increase the likelihood of survival, according to a study in mice led by scientists at the UCLA Jonsson Comprehensive Cancer Center.
Internationally renowned physician-scientist Dr. Beth Karlan, director of cancer population genetics at the UCLA Jonsson Comprehensive Cancer Center, is being honored with the Lifetime Achievement Award from the International Gynecologic Cancer Society (IGCS) for her contributions to gynecologic cancer research and clinical practice.
Research by a UCLA-led team has determined that the number of COVID-19 cases and the number of deaths from the disease both increased dramatically after states lifted eviction moratoriums that had been in place to protect people who were struggling to make rent payments during the pandemic.
In a world dealing with the worst public health crisis in a century, the current U.S. system for tracking deaths suffers from organizational, political and procedural flaws that actually put public health and safety at risk, and requires significant updates and reform to solve the problems laid bare by the COVID-19 pandemic.
The UCLA Fielding School of Public Health's WORLD Policy Analysis Center (WORLD) released the first study to systematically analyze how common sick leave eligibility criteria in the U.S. affect access and to examine sick leave policies globally to understand whether these criteria are necessary. The research found marked racial and gender gaps in leave access in the U.S. due to restrictions targeting workers at small businesses, part-time workers, and workers at new jobs.
Findings could help pave the way for cancer therapies that target TAF12, potentially stopping transcription in cancer cells and helping decrease the growth of cancerous tumors.
With California state vaccination rates slowing, and guidelines on mask wearing and social gatherings changing, the UCLA Center for Health Policy Research (CHPR) has released new data from the 2021 California Health Interview Survey (CHIS) that sheds light on Californians’ views on getting the vaccine and following suggested safety protocols.
A chemical modification that occurs in some RNA molecules as they carry genetic instructions from DNA to cells’ protein-making machinery may offer protection against non-alcoholic fatty liver, a condition that results from a build-up of fat in the liver and can lead to advanced liver disease, according to a new study by UCLA researchers. The study, conducted in mice, also suggests that this modification — known as m6A, in which a methyl group attaches to an RNA chain — may occur at a different rate in females than it does in males, potentially explaining why females tend to have higher fat content in the liver. The researchers found that without the m6A modification, differences in liver fat content between the sexes were reduced dramatically.
Unlike nearly three-quarters of high-income countries, however, the U.S. has no laws specifically limiting the detention of accompanied migrant and asylum-seeking children, according to a new study by the UCLA Fielding School of Public Health's WORLD Policy Analysis Center (WORLD).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
